Clinical trial
A Clinical Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 (SmartGuard®) on Blood Lead Levels in Children
NCT04891666 is registered in ClinicalTrials.gov with Novozymes A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 (SmartGuard®) on Blood Lead Levels in Children
- Lead sponsor
- Novozymes A/S
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 6, 2021
- Completion date
- March 17, 2023
- Enrollment
- 66 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
elevated blood lead levels